Genedata, a leading provider of in silico solutions for pharmaceutical R&D and related life sciences, today announced the Expressionist Migration Program, a new offering that bundles the Genedata Expressionist system with a targeted set of professional services. The Expressionist Migration Program provides researchers and bioinformaticians with a proven set of tools and services for the migration of microarray, mass spectrometry and related data from legacy and proprietary systems.
“While the landscape of bioinformatics vendors is ever-changing, the research process must continue uninterrupted,” said Dr. Othmar Pfannes, CEO of Genedata. “The Expressionist Migration Program is an offering packaged specifically for those researchers whose organizations may be in a state of flux due to new market conditions. As an employee-owned company, not affiliated with another entity, Genedata uniquely offers its customers an established and scalable portfolio of drug discovery and life science research solutions, professional services, and ongoing support,” continued Pfannes. “Expressionist Migration provides a practical transition path for customers looking for a cost-effective and efficient solution, which accelerates the time to value and ensures returns on previous investments.”
The Expressionist Migration Program offers special terms on bundled software and professional services tailored to support smooth transition of internal or third-party data sources into Genedata Expressionist. Built upon an open and scalable architecture, Genedata Expressionist is an enterprise solution, which integrates, stores and analyzes transcriptomics, proteomics, and metabolomics data as well as a variety of phenotypic data. With the Genedata Expressionist Database as its foundation, Expressionist consists of several modules supporting high throughput, standardized and workflow-based data processing and statistical analysis. Its modular, three-tier architecture seamlessly integrates with a wide range of pharmaceutical, biotechnological, and agricultural R&D processes.
To support end users during the transition period, the Expressionist Migration Program also provides a portfolio of professional services spanning expert or administrative training, scientific consulting, and custom software development.
Genedata (genedata.com) develops and globally markets sophisticated computational solutions for drug discovery and related research processes in the life sciences. Genedata’s solutions enable scientists to process, integrate, analyze, and manage large and complex experimental data sets generated by high throughput technologies. Solutions include Genedata Phylosopher® for target discovery and integrative biological data management, Genedata Screener® for automated high throughput screening and high content screening, and Genedata Expressionist® for biomarker discovery and personalized medicine. Founded in 1997, Genedata is privately held, with headquarters in Basel, Switzerland, and offices in Boston & San Francisco, USA, Konstanz & Munich, Germany and Tokyo, Japan.
Jackie Thrasivoulos, Genedata Public Relations
P:+1 508 881 3109
The statements in this press release that relate to future plans, events or performance are forward-looking statements that involve risks and uncertainties, including risks associated with uncertainties related to contract cancellations, developing risks, competitive factors, uncertainties pertaining to customer orders, demand for products and services, development of markets for the Company's products and services. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. The Company undertakes no obligation to release publicly the result of any revisions to these forward-looking statements that may be made to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.
All product and service names mentioned are the trademarks of their respective companies.